Axience

Axience is a French pharmaceutical company specializing in the development and marketing of veterinary products, particularly in the fields of anesthesia, analgesia, and animal hygiene. Founded in 2002 and headquartered in Pantin, France, the company established a strong presence in the European veterinary market with a portfolio that includes both proprietary and licensed products. In July 2021, Axience was acquired by Dechra Pharmaceuticals, a global leader in veterinary medicine, to strengthen Dechra's position in the French market and expand its anesthesia and analgesia offerings. The company's product range serves both companion animals and livestock, focusing on high-quality therapeutic solutions for veterinarians. Axience is recognized for its technical expertise and its role in providing essential sedative and pain management tools to the veterinary community.